Apotex issues recall of eye treatment over cracked bottle caps
Generics manufacturer Apotex is voluntarily pulling six lots of its brimonidine tartrate ophthalmic solution off the shelves after cracks were reported on some bottle caps.
Broken caps can impact the sterility of the product, and even lead to a potential adverse event, the company said. The drug is used to reduce intraocular pressure for patients with open-angle glaucoma or ocular hypertension, and affected batches were distributed across the US between April 5 of last year and Feb. 22, 2023.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
